Results 41 to 50 of about 3,917,698 (342)
Dermatology Online Journal, 2009 A 78-year-old man presented with an eight-month history of folliculocentric, pink, hyperkeratotic papules and plaques with thick white scale that involved the entire body, with confluence on the buttocks and genitalia. A biopsy specimen demonstrated superficial and focal, mild perivascular and perifollicular, band-like lymphocytic infiltrate and ...
Brauer, Jeremy +3 more
openaire +4 more sources
Clinical Features of Drug Eruption in An Indonesian Tertiary Hospital
Majalah Kedokteran BandungDrug eruption is a response to drugs undergoing sensitization, which is mediated by the immune system. Clinical features of drug eruptions, such as maculopapular drug eruption, Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), and drug ...
Enny Rohmawaty +2 more
doaj +1 more source
Modafinil-induced Fixed Drug Eruption
Indian Journal of Psychological Medicine, 2012 Modafinil is a stimulant drug widely used to promote wakefulness in a variety of psychiatric and neurological conditions. Modafinil-induced severe dermatologic reactions are uncommon but serious side effects.
Girish Vasant Gaikwad +1 more
doaj +1 more source
Azithromycin induced bullous fixed drug eruption
Indian Journal of Pharmacology, 2016 Fixed drug eruption (FDE) is a common type of drug eruption seen in skin clinics. It is characterized by solitary or multiple, round to oval erythematous patches with dusky red centers, some of which may progress to bulla formation.
Anupam Das +3 more
semanticscholar +1 more source
Clinical analysis of HIV/AIDS patients with drug eruption in Yunnan, China
Scientific Reports, 2016 Drug eruption is the most common clinical presentation in patients with HIV/AIDS. The systemic clinical and risk factors associated with drug eruption remain unknown.
Yu-Ye Li +8 more
semanticscholar +1 more source
Extramedullary Disease—Achilles Heel in Myeloma?
American Journal of Hematology, EarlyView.ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar +7 more
wiley +1 more source
Bullous fixed drug eruption due to erlotinib: A rare case report
Annals of Oncology Research and TherapyFixed Drug Eruption is one of the most common cutaneous adverse drug reactions, of which the bullous variant is a more severe form. Epidermal growth factor (EGFR) inhibitors are one of the prime chemotherapeutic agents used recently in various ...
Kallolinee Samal +3 more
doaj +1 more source
Fixed drug eruption resulting from fluconazole use: a case report
Journal of Medical Case Reports, 2009 Introduction Fluconazole is a widely used antifungal agent with a possible side effect of fixed drug eruption. However, this adverse drug effect is absent from the reported list of possible side effects of fluconazole.
Tavallaee Mahkam, Rad Mahnaz Mahmoudi
doaj +1 more source
Fixed drug eruption due to levocetirizine
Journal of Pharmacology and Pharmacotherapeutics, 2016 A fixed drug eruption (FDE) is a cutaneous adverse drug reaction due to Type IV or delayed cell-mediated hypersensitivity. Antihistamines, which antagonize the action of histamine during an allergic reaction by blocking the H 1 histamine receptors, are ...
R. Jhaj, D. Asati, D. Chaudhary
semanticscholar +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source